bioRxiv Science⌕ Search

Biology subjects

Billa, A.

Publications and source records attributed to Billa, A..

2 recordsLinked to original sources

Analysis of the DNA-binding domain of the Pseudomonas aeruginosa quorum sensing transcription factor LasR

Many bacteria engage in quorum sensing (QS), a cell-cell communication system used to coordinate group behaviors. In one type of QS, acyl-homoserine lactone signals generated by LuxI homologs bind to LuxR homolog transcription factors, usually resulting in gene activation. The genome of Pseudomonas aeruginosa encodes three such LuxR homologs: LasR, RhlR, and QscR. Of these, LasR regulates the most genes, including that encoding RhlR. There is strong evidence that, during chronic infections, lasR and other genes encoding LuxR-type regulators are under strong selective pressure for mutations that both inactivate and modulate their function. Thus, we wondered if some mutations in the lasR gene might result in a protein with affinity for promoters usually regulated by the other LuxR homologs; to do so, we investigated the DNA-binding domain (DBD) of LasR through alanine substitution. As expected, we found that most alanine substitutions across the LasR DBD led to loss of function, as did previously identified clinical LasR DBD variants. Additionally, some alanine mutants were indistinguishable from the wild type. We describe a handful of variant LasR polypeptides that unexpectedly exhibit enhanced regulation on a RhlR-regulated gene, which conferred a fitness defect when competed against the wild type. Most other LasR variants had a competitive advantage. Our results suggest a pathway for expansion of the regulon of LuxR-homolog transcription factors, but also that such mutations may be disfavored due to the incurred metabolic burden.

microbiology↗

Immunoinformatic Designing and Evaluation of a Broad-Spectrum Multiepitope Vaccine Against MDR Acinetobacter baumannii, Klebsiella pneumoniae and Pseudomonas aeruginosa

Acinetobacter baumannii, Klebsiella pneumoniae and Pseudomonas aeruginosa are among the multidrug-resistant (MDR) Gram-negative pathogens that pose a growing threat, necessitating novel preventive measures in addition to traditional antibiotics. By using advanced immunoinformatics methods, highly conserved and immunogenic epitopes for B-cells and T-cells were selected from major virulence-associated proteins (LptE, YiaD, MrkD, PhoE, OprF, and Zot), which exhibited high antigenicity (VaxiJen scores 0.74-2.75) and 98.87% global population coverage. The construct vaccine comprises 50S ribosomal protein L7/L12 adjuvant and PADRE sequence for immunogenicity enhancement, with structural validation indicating stability (96.3% residues in the total allowed Ramachandran regions). High-affinity interactions with TLR2/TLR4 (binding energies: -1009.6 to -1079.6 kcal/mol) were found through molecular docking, and immune simulations suggested strong humoral (IgM/IgG) and cellular (IFN-{gamma}/IL-12) responses. Importantly, MEP vaccines can overcome major drawbacks of traditional vaccines by (1) offering cross-strain protection via conserved epitopes, (2) lowering the need for antibiotics through infection prevention, and (3) providing affordable options for healthcare systems affected by MDR infections. These findings demonstrate the MEP constructs potential as a preventative measure against nosocomial infections, which may have implications for combating the global AMR epidemic. Further experimental validation is needed to verify its efficacy.

immunology↗